Skip to main content

Table 1 Demographics of study participants

From: Patient participation in end-stage kidney disease care: variation over time and effects of staff-directed interventions - a quasi-experimental study

Variable

Groups in the intervention n (%)

 

CG 78 (22)

SDG 86 (24)

FIG 194 (54)

 
 

n (%),

mean (SD) and range

n (%)

mean (SD) and range

n (%)

mean (SD) and range

p-value

Sex and age n (%)

       

 Men 221 (62)

51 (23),

69 (13.4), 28–86

47 (21),

71 (13.2), 29–89

123 (56),

71 (12.3), 31–92

0.687

 Women 134 (37)

27 (20.5)

75 (10), 57–94

38 (28),

70 (12,5), 39–89

69 (51.5)

69 (11.1), 43–89

0.064

Missing value 3 (1)

 

1 (0.5)

2 (0.5)

 

Years in kidney care, n (%)

315 (88)

  ≤ 2 years, 28 (8)

9 (3)

4 (1.5)

15 (5)

0.664

 3–5 years, 106 (30)

22 (7)

24 (8)

60 (19.5)

  ≥ 6 years,175 (49)

36 (11.5)

47 (15)

92 (29.5)

Missing value 43 (12)

11

11

27

 

Years on dialysis, n (%)

167 (90)

 

  ≥ 2 years, 71 (43)

14 (8.5)

14 (8.5)

43 (26)

0.162

 3–5 years, 61 (37)

7 (4)

22 (13.5)

32 (19)

  ≥ 6 years, 34 (20)

9 (5.5)

10 (6)

15 (9)

Missing value, 18 (10)

4

6

9

 

Treatment group, n (%)

 

 Out of patient care, 173 (48)

44 (25)

34 (20)

95 (55)

0.380

 KRT, 185 (52)

34 (18)

52 (28)

99 (54)

Type of dialysis treatment, 146

0.459

 Haemodialysis, 126 (68)

23 (16)

38 (26)

65 (45)

 

 Peritoneal dialysis, 19 (10.5)

3 (2)

6 (4)

10 (7)

 Transplanted, 1 (0.05)

0

0

1 (0.5)

Missing value, 39 (21)

8

8

23

 

Distribution across the sites

A) 36 (10); B) 68 (19); C) 90 (25); D) 30 (8.5); E) 36 (10); F) 1 (0.5); G) 19 (5); H) 29 (8); i) 49 (14)

  1. Note: Data expressed as n = frequencies, % = percentages, mean (SD) ± range. CG Control group, SDG Standard dissemination group, FIG Facilitated implementation group. p–value refers to Kruskal–Wallis’s test (p < 0.05)